Crinetics Pharmaceuticals
Why Robinhood?
You can watch CRNX and buy or sell other stocks, ETFs, and their options commission-free!About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CRNX Key Statistics
Stock Snapshot
Crinetics Pharmaceuticals(CRNX) stock is priced at $84.95, giving the company a market capitalization of 9.01B. It carries a P/E multiple of -16.84.
On 2026-09-08, Crinetics Pharmaceuticals(CRNX) stock opened at —, reached a high of —, and a low of —.
The Crinetics Pharmaceuticals(CRNX)'s current trading volume is 0, compared to an average daily volume of 1.3M.
In the last year, Crinetics Pharmaceuticals(CRNX) shares hit a 52-week high of $85.01 and a 52-week low of $31.49.
In the last year, Crinetics Pharmaceuticals(CRNX) shares hit a 52-week high of $85.01 and a 52-week low of $31.49.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.